Wednesday, November 9, 2016

BRIEF-Mylan CEO sees EpiPen accounting for 6 pct of 2017 sales

* Mylan sees generic drugs price erosion in mid single

digits for rest of year

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)